Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michael T. Lewis
Observed names:
Lewis, Michael T.,
M. T. Lewis,
Michael Lewis,
Michael T. Lewis
Institutions:
Baylor College of Medicine,
Dan L Duncan Comprehensive Cancer Center
Observed institutions:
Baylor College of Medicine,
VA West Los Angeles Medical Center,
Dan L Duncan Comprehensive Cancer Center
ORCID:
0000-0002-6330-4007
Observed ORCID:
0000-0002-6330-4007
OpenAlex ID:
A5103399460
IRE1α silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer
2024
·
Longyong Xu
, Fanglue Peng
, et al.
·
Cell
·
94
Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation
2015
·
Ze-Yi Zheng
, Lin Tian
, et al.
·
Cell Reports
·
72
Identification and Characterization of Separase Inhibitors (Sepins) for Cancer Therapy
2014
·
Nenggang Zhang
, Kathleen Scorsone
, et al.
·
SLAS DISCOVERY
·
45
Orphan nuclear receptor 4A1 (NR4A1) and NR4A2 are endogenous regulators of CD71 and their ligands induce ferroptosis in breast cancer
2025
·
Arafat Rahman Oany
, Srijana Upadhyay
, et al.
·
Cell Death and Disease
·
8
PDF
Surface Marker Identification to Capture Live Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer
2026
·
Bree M. Lege
, Khushali J. Patel
, et al.
·
Cancer Research Communications
·
3
Co-occurrence of transcriptionally distinct persister cell states underpins neoadjuvant therapy resistance in triple‑negative breast cancer
2026
·
Yu Zhang
, Fatemeh Ahmadi Moughari
, et al.
·
Genome Medicine
·
2
LIG1 Loss in TP53 -mutant Triple-Negative Breast Cancer Rewires DNA Repair and Confers Sensitivity to PARP–ATR Inhibitor Combinations
2026
·
Anh Minh Tran Huynh
, Jonathan T. Lei
, et al.
·
Molecular Cancer Therapeutics
·
1
Cellular stemness identifies high-risk ductal carcinoma in situ and offers a therapeutic interception opportunity
2026
·
E. Schueddig
, V. Kochat
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
Co-occurrence of transcriptionally distinct persister cell states underpins neoadjuvant therapy resistance in triple‑negative breast cancer
2026
·
Zhang, Yu
, Moughari, Fatemeh Ahmadi
, et al.
·
Figshare
Abstract P2-04-17: The MIRACCL Portal for Comparing Patient and PDX Response Using Cancer Image Features and Genomics in Co-Clinical Breast Cancer Trials
2025
·
Heidi Dowst
, Fei Zheng
, et al.
·
Clinical Cancer Research
Abstract 1956: A subset of prostate cancer cells with loss of MST1 expression confers resistance to castration through YAP1-AR interactions
2015
·
Bekir Cinar
, Gamze Kuser Abali
, et al.
·
Cancer Research
Show more works
View as search
Works count:
13
Citation count:
226
H-index:
4
I10-index:
3
Year
Topic
Type